Caption Management’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Caption Management’s Portfolio CRXTW Stock Details CRXTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-140,821	Closed	–	–	1889
2022 Q3	$0	Hold	140,821	–	–	﹤0.01%	1974
2022 Q2	$11K	Hold	140,821	–	–	﹤0.01%	1382
2022 Q1	$20K	Hold	140,821	–	–	﹤0.01%	1389
2021 Q4	$41K	Hold	140,821	–	–	﹤0.01%	1518
2021 Q3	$106K	Buy	+140,821	New	+$106K	﹤0.01%	1403

Caption Management's CRXTW Position: Q4 2022 in Review

Caption Management sold out of Clarus Therapeutics Holdings, Inc. Warrants (CRXTW) in Q4 2022, closing a stake of 140,821 shares.

Caption Management first reported a position in CRXTW in Q3 2021 and held it in 5 quarters. The position peaked at $106K in Q3 2021. 0 funds tracked by Wall St. Rank hold CRXTW as of Q4 2022.

Caption Management reported no remaining Clarus Therapeutics Holdings, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
Caption Management sold 140,821 Clarus Therapeutics Holdings, Inc. Warrants shares in Q4 2022.
Caption Management first reported a position in Clarus Therapeutics Holdings, Inc. Warrants in Q3 2021 and held it in 5 quarters.
Caption Management's Clarus Therapeutics Holdings, Inc. Warrants position peaked at $106K in Q3 2021.
0 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Warrants as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.